Search Results - "Nardin, Matteo"

Refine Results
  1. 1
  2. 2
  3. 3

    Antiplatelet Effect of Low-Dose Prasugrel in Elderly Patients Undergoing Percutaneous Coronary Interventions by Verdoia, Monica, Nardin, Matteo, Gioscia, Rocco, Rognoni, Andrea, De Luca, Giuseppe

    Published in Current vascular pharmacology (01-01-2024)
    “…Low-dose prasugrel (5 mg) has been proposed for patients with Acute Coronary Syndrome (ACS) and advanced age or low body weight. However, the routine use of…”
    Get more information
    Journal Article
  4. 4

    Impact of Immunity on Coronary Artery Disease: An Updated Pathogenic Interplay and Potential Therapeutic Strategies by Laera, Nicola, Malerba, Paolo, Vacanti, Gaetano, Nardin, Simone, Pagnesi, Matteo, Nardin, Matteo

    Published in Life (Basel, Switzerland) (01-10-2023)
    “…Coronary artery disease (CAD) is the leading cause of death worldwide. It is a result of the buildup of atherosclerosis within the coronary arteries. The role…”
    Get full text
    Journal Article
  5. 5

    Association between vitamin D deficiency and serum Homocysteine levels and its relationship with coronary artery disease by Verdoia, Monica, Nardin, Matteo, Gioscia, Rocco, Saghir Afifeh, Arraa Maddalena, Viglione, Filippo, Negro, Federica, Marcolongo, Marco, De Luca, Giuseppe

    Published in Journal of thrombosis and thrombolysis (01-08-2021)
    “…Homocysteine (Hcy) elevation and vitamin D deficiency have emerged as potential markers of coronary artery disease (CAD). However, even tough hypovitaminosis D…”
    Get full text
    Journal Article
  6. 6

    Relationship between adenosine A2a receptor polymorphism rs5751876 and fractional flow reserve during percutaneous coronary intervention by Nardin, Matteo, Verdoia, Monica, Negro, Federica, Suryapranata, Harry, Khedi, Elvin, De Luca, Giuseppe

    Published in Heart and vessels (01-10-2020)
    “…Fractional flow reserve (FFR) assessed during adenosine-induced maximal hyperemia has emerged as a useful tool for the guidance of percutaneous coronary…”
    Get full text
    Journal Article
  7. 7

    Single Inhaler LABA/LAMA for COPD by Malerba, Mario, Foci, Valentina, Patrucco, Filippo, Pochetti, Patrizia, Nardin, Matteo, Pelaia, Corrado, Radaeli, Alessandro

    Published in Frontiers in pharmacology (25-04-2019)
    “…Chronic obstructive pulmonary disease (COPD) is a common disabling disease characterized by progressive airflow obstruction. Great efforts were spent in the…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Impact of gender on immature platelet count and its relationship with coronary artery disease by Negro, Federica, Verdoia, Monica, Tonon, Francesco, Nardin, Matteo, Kedhi, Elvin, De Luca, Giuseppe

    Published in Journal of thrombosis and thrombolysis (01-05-2020)
    “…The impact of platelet parameters on the cardiovascular risk is still debated. Gender differences in platelet volume indexes and turnover have been previously…”
    Get full text
    Journal Article
  10. 10

    Impact of aging on immature platelet count and its relationship with coronary artery disease by Verdoia, Monica, Nardin, Matteo, Negro, Federica, Tonon, Francesco, Gioscia, Rocco, Rolla, Roberta, De Luca, Giuseppe

    Published in Platelets (Edinburgh) (16-11-2020)
    “…Despite the fact that elderly patients represent a prevalent and challenging population in the current practice, few data exist on the impact of platelet…”
    Get full text
    Journal Article
  11. 11

    Radial vs Femoral Approach in Acute Coronary Syndromes: A Meta- Analysis of Randomized Trials by Nardin, Matteo, Verdoia, Monica, Barbieri, Lucia, Schaffer, Alon, Suryapranata, Harry, De Luca, Giuseppe

    Published in Current vascular pharmacology (01-01-2018)
    “…Substantial improvements have been achieved with percutaneous coronary intervention (PCI) for the treatment of Acute Coronary Syndromes (ACS). Nevertheless,…”
    Get more information
    Journal Article
  12. 12

    Single-inhaler triple therapy utilizing the once-daily combination of fluticasone furoate, umeclidinium and vilanterol in the management of COPD: the current evidence base and future prospects by Malerba, Mario, Nardin, Matteo, Santini, Giuseppe, Mores, Nadia, Radaeli, Alessandro, Montuschi, Paolo

    “…Maintenance pharmacological treatment for stable chronic obstructive pulmonary disease (COPD) is based on inhaled drugs, including long-acting muscarinic…”
    Get full text
    Book Review Journal Article
  13. 13

    Vitamin D and Cardiovascular Diseases: From Physiology to Pathophysiology and Outcomes by Nardin, Matteo, Verdoia, Monica, Nardin, Simone, Cao, Davide, Chiarito, Mauro, Kedhi, Elvin, Galasso, Gennaro, Condorelli, Gianluigi, De Luca, Giuseppe

    Published in Biomedicines (01-04-2024)
    “…Vitamin D is rightly recognized as an essential key factor in the regulation of calcium and phosphate homeostasis, affecting primary adequate bone…”
    Get full text
    Journal Article
  14. 14

    Impact of adenosine A2a receptor polymorphism rs5751876 on platelet reactivity in ticagrelor treated patients by Nardin, Matteo, Verdoia, Monica, Pergolini, Patrizia, Rolla, Roberta, Barbieri, Lucia, Marino, Paolo, Bellomo, Giorgio, Kedhi, Elvin, Suryapranata, Harry, Carriero, Alessandro, De Luca, Giuseppe

    Published in Pharmacological research (01-03-2018)
    “…[Display omitted] Dual antiplatelet therapy constitutes a key point in the management of patients with acute coronary syndromes. In particular, ticagrelor, an…”
    Get full text
    Journal Article
  15. 15

    Platypnoea-Orthodeoxia Syndrome in COVID-19 by Salvotti, Francesca, Poiatti, Francesco, Bressa, Stefano, Montani, Giovanni, Nardin, Matteo, Rizzoni, Damiano

    “…Platypnoea-orthodeoxia syndrome (POS) is a rare disorder and its pathophysiology has puzzled clinicians for years. Few cases of POS are described in COVID-19…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    Drug-coated balloons in high-risk patients and diabetes mellitus: A meta-analysis of 10 studies by Verdoia, Monica, Nardin, Matteo, Rognoni, Andrea, Cortese, Bernardo

    “…Despite the improvements in drug eluting stents (DES) technology, suboptimal results have been observed in certain higher-risk subsets of patients, as in…”
    Get full text
    Journal Article